IPD vs NEU

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IPD

IMPEDIMED FPO [IPD]

48LOW

NEU

NEUREN FPO NZ [NEU]

47LOW

Score Breakdown

IPD NEU
Technical
57
61
Catalyst
55
50
Sentiment
50
50
Fundamental
95
62
Momentum
30
26
Risk Gate
27
43

Key Metrics

IPD Metric NEU
$22.0MMarket Cap$2.1B
6.9MAvg Volume (20d)725K
N/AShort Interest+4.9%
$0.05952-Week High$22.985
$0.00552-Week Low$11.000
+0.0%Daily Change+0.2%
$0.006Reference Price$16.530
-117.9%ROE+8.7%
-171.3%Profit Margin+47.1%

Active Signals

IPD Signals

●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (5 quarters)
●Low P/S ratio (1.5x)
●Strong revenue growth (+25%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week low (2% of range)

NEU Signals

●Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Revenue in sharp decline (-81%)
●Piotroski F-Score strong (7/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Post-earnings drift: negative surprise (SUE -10)
●Earnings in sharp decline (-88% QoQ)

Ask Scout AI to compare IPD and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IDT vs IPD →MSB vs PKP →ENP vs MSB →MSB vs PEB →ENP vs PKP →
IPD Full Analysis → NEU Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).